APA (7th ed.) Citation

DC, S., MA, T., E, E., M, S., T, V., SA, J., & M, L. (2024). Continuous Glucose Monitoring Profiles and Health Outcomes After Dapagliflozin Plus Saxagliptin vs Insulin Glargine. The Journal of clinical endocrinology and metabolism, 109(12), e2261. https://doi.org/10.1210/clinem/dgae105

Chicago Style (17th ed.) Citation

DC, Simonson, Testa MA, Ekholm E, Su M, Vilsbøll T, Jabbour SA, and Lind M. "Continuous Glucose Monitoring Profiles and Health Outcomes After Dapagliflozin Plus Saxagliptin Vs Insulin Glargine." The Journal of Clinical Endocrinology and Metabolism 109, no. 12 (2024): e2261. https://doi.org/10.1210/clinem/dgae105.

MLA (9th ed.) Citation

DC, Simonson, et al. "Continuous Glucose Monitoring Profiles and Health Outcomes After Dapagliflozin Plus Saxagliptin Vs Insulin Glargine." The Journal of Clinical Endocrinology and Metabolism, vol. 109, no. 12, 2024, p. e2261, https://doi.org/10.1210/clinem/dgae105.